In both astrocytes-enriched human cell cultures and glioma cells incubated with IL-1β, immunocytochemistry demonstrated a lower percentage of Kir4.1-labeled cells as compared to controls (Figure 3A-F). This evidence concerns the gene KCNJ10 and central nervous system cancer.